stockrowAlcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) Return on assets
Alcon's return on assets over the twelve months to 30 June 2026 was 2.06%, down 1.1 percentage points from fiscal 2025 (3.17%). Over the past ten years it has ranged from −2.40% (fiscal 2019) to 3.40% (fiscal 2024); the current reading is higher than 80% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 3.17% | (0.23) |
| FY2024 | 3.40% | 0.09 |
| FY2023 | 3.31% | 2.14 |
| FY2022 | 1.17% | (0.18) |
| FY2021 | 1.35% | 3.27 |
| FY2020 | −1.92% | 0.48 |
| FY2019 | −2.40% | (1.57) |
| FY2018 | −0.83% | (2.69) |
| FY2017 | 1.86% | 2.46 |
| FY2016 | −0.60% | — |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| RMD ResMed Inc. compare | 19.3% |
| WST West Pharmaceutical Services, Inc. compare | 15.7% |
| ALGN Align Technology, Inc. compare | 7.71% |
| COO The Cooper Companies, Inc. compare | 4.55% |
| ALC Alcon | 2.06% |
| BDX Becton, Dickinson and Company compare | 1.78% |
| MDLN Medline Inc. compare | 1.49% |
| SOLV Solventum Corporation compare | 1.11% |
| BAX Baxter International Inc. compare | −3.57% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on ALC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement